RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Chronic infectious disease
View Complete Description
 Individual Studies |
|
|---|---|
|
|
Homo sapiens
|
RNA Expression
-
Waking up T cells to counteract chronic infections.
Authors: Barry T Rouse, David Masopust
Trends in immunology 2006 May -
Molecular determinants of a symbiotic chronic infection.
Authors: Katherine E Gibson, Hajime Kobayashi, Graham C Walker
Annual review of genetics 2008
Thought leaders and organizations working on research involving chronic infection.
- Gilead Sciences
- National Heart, Lung, and Blood Institute (NHLBI)
- Anadys Pharmaceuticals
- Stanford University
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDD…
- Emory University School of Medicine
- Wistar Institute
- Harvard Medical School and Brigham and Women's Hospital
- Massachusetts Institute of Technology
- Beth Israel Deaconess Medical Center
-
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
conditions: Primary HIV (Acute or Early) ; Chronic HIV Infection
interventions: Tenofovir disoproxil fumarate and emtricitabine (TDF/FTC; Truvada) plus the integrase inhibitor, raltegravir.
-
Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile
conditions: Hepatitis C Virus Chronic Infection
interventions: none
-
Transgene presents additional Phase I data for TG4040 in Hepatitis C chronically infected patients
Bionity.COM. - April 26, 2009 -
Transgene Presents Additional Phase I Data For TG4040 In Hepatitis C Chronically Infected Patients At EASL And Is Now Preparing For Phase II Trial
Medical News Today. - April 24, 2009
Community
Gabrielle Belz
Professor
The Walter and Eliza Hall Institute of Medical Research
Humphrey Mkali
Statistician
Kilimanjaro Clinical Research Institute
-
Hepatitis C
10 members
